J.V.P.Super Speciality Hospitals Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 01-07-2024
- Paid Up Capital ₹ 1.85 Cr
as on 01-07-2024
- Company Age 24 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.69 Cr
as on 01-07-2024
- Revenue 13.23%
(FY 2020)
- Profit 30.09%
(FY 2020)
- Ebitda 53.62%
(FY 2020)
- Net Worth -3.76%
(FY 2020)
- Total Assets 0.72%
(FY 2020)
About J.V.P.Super Speciality Hospitals
The Company is engaged in the Travel And Hospitality Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.85 Cr.
The company currently has active open charges totaling ₹1.69 Cr.
Rajaram Kikkeri, Jayaramreddy Singireddy, and Arrabottu Reddy serve as directors at the Company.
- CIN/LLPIN
U85110TG2000PTC033412
- Company No.
033412
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
31 Jan 2000
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at J.V.P.Super Speciality Hospitals?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rajaram Kikkeri | Additional Director | 22-Jan-2024 | Current |
Jayaramreddy Singireddy  | Director | 01-Jul-2013 | Current |
| Arrabottu Reddy | Director | 31-Jan-2000 | Current |
Financial of J.V.P.Super Speciality Hospitals.
J.V.P.Super Speciality Hospitals Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 13.23% increase. The company also saw a substantial improvement in profitability, with a 30.09% increase in profit. The company's net worth dipped by a decrease of 3.76%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of J.V.P.Super Speciality Hospitals?
In 2020, J.V.P.Super Speciality Hospitals had a promoter holding of 66.68% and a public holding of 33.32%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 28 Feb 2020 | ₹1.50 M | Open |
Ge Capital Services India Creation Date: 30 Jun 2009 | ₹0.66 M | Open |
Icici Bank Limited Creation Date: 18 Mar 2003 | ₹1.26 M | Open |
How Many Employees Work at J.V.P.Super Speciality Hospitals?
Unlock and access historical data on people associated with J.V.P.Super Speciality Hospitals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of J.V.P.Super Speciality Hospitals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped J.V.P.Super Speciality Hospitals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
